The Patient-Specific Goal-Setting Method<\/strong> (Dutch: Pati\u00ebnt Specifieke Goal-setting methode<\/em>; PSG<\/strong>) is an interactive, patient-centered clinimetric and clinical decision-making framework designed to operationalize collaborative goal construction, intervention planning, and longitudinal functional monitoring within physical therapy and rehabilitation sciences. Developed by Dr. Anita Stevens and colleagues at Zuyd University of Applied Sciences, the PSG represents a comprehensive paradigm shift and methodological enhancement of the traditional Patient-Specific Complaints instrument (Pati\u00ebnt Specifieke Klachten<\/em>, PSK), which was historically adapted from Stratford’s Patient-Specific Functional Scale<\/a> (PSFS). Unlike static outcome measures that evaluate patient deficits in isolation, the PSG systematically integrates an idiographic assessment protocol into the iterative clinical reasoning cycle across four explicit phases: (1) functional problem clarification, (2) goal formulation, (3) collaborative treatment planning, and (4) outcome evaluation. Central to the PSG’s psychometric architecture is the deliberate reframing of the measurement continuum: the instrument transitions from a deficit-based scoring metric assessing “difficulty with execution” to an asset-based, positive health metric assessing the patient’s “ability to perform” (mogelijkheid tot uitvoeren<\/em>) chosen activities on a 0 to 10 numerical rating scale (NRS), where higher scores denote superior functional capacity. Psychometric evaluations demonstrate high clinimetric responsiveness, substantial test-retest reliability ($ICC > 0.85$<\/span>), and superior patient engagement characteristics compared to generic nomothetic indices. This article provides an exhaustive academic analysis of the PSG, delineating its theoretical foundation in Self-Determination Theory<\/a> and Goal-Setting Theory, its clinimetric validation, administration architecture, and clinical implementation parameters.<\/p>\n Patient-Specific Goal-Setting Method, PSG, goal setting, physical therapy, rehabilitation, shared decision-making, clinimetrics, Patient-Specific Functional Scale, Self-Determination Theory, positive health, functional capacity, outcome measurement<\/p>\n The Patient-Specific Goal-Setting Method was developed and standardized by Dr. Anita Stevens<\/strong> and colleagues within the Research Centre for Autonomy and Participation<\/strong> (Lectoraat Autonomie en Participatie<\/em>) at Zuyd University of Applied Sciences<\/strong> (Zuyd Hogeschool<\/em>) in Heerlen, the Netherlands, in collaborative alignment with rehabilitation clinicians, physical therapy specialists, and health services researchers across Dutch primary and secondary care networks.<\/p>\n The primary clinical and psychometric purpose of the Patient-Specific Goal-Setting Method is to provide healthcare professionals—primarily physical therapists, occupational therapists, and rehabilitation specialists—with an evidence-based, structured, yet highly personalized instrument that embeds measurement directly into the clinical therapeutic alliance. Conventional standardized, nomothetic health-related quality of life (HRQoL<\/a>) instruments (such as the SF-36, EuroQol-5D) and condition-specific questionnaires (e.g., the Oswestry Disability Index or the Western Ontario and McMaster Universities Osteoarthritis Index) rely on fixed inventories of functional activities. Although these fixed batteries provide standardized cross-sectional benchmarks, they routinely fail to capture idiosyncratic activities that are of critical, self-defining value to an individual patient’s daily life, vocational obligations, or recreational pursuits.<\/p>\n To address this clinical limitation, the PSG functions as an idiographic measurement system designed to achieve three foundational objectives:<\/p>\n The PSG measures individualized functional ability within meaningful life activities<\/strong>, conceptualized through an integrative biopsychosocial lens. Rather than treating physical function as a static biological variable, the construct measured by the PSG is inherently cognitive-behavioral and phenomenological: it evaluates an individual’s appraisal of their functional competence, perceived autonomy, and self-efficacy when engaging in self-selected everyday activities.<\/p>\n The construct is operationalized through a four-phase methodological process, each tapping into distinct psychological and functional sub-constructs:<\/p>\n The conceptual foundation of the Patient-Specific Goal-Setting Method rests on the intersection of four prominent behavioral and health sciences frameworks:<\/p>\n According to Self-Determination Theory<\/a>, human motivation and psychological well-being require the satisfaction of three fundamental psychological needs: autonomy<\/em> (experiencing oneself as the author of one’s actions), competence<\/em> (feeling effective in interacting with the social and physical environment), and relatedness<\/em> (feeling connected to and understood by others). The PSG directly operationalizes SDT in clinical practice:<\/p>\n Developed by Edwin Locke and Gary Latham, Goal-Setting Theory<\/a> posits that specific, challenging, yet attainable goals lead to higher task performance than vague “do your best” intentions or absent goal structures. The PSG incorporates structured goal-setting mechanisms that guide patients to formulate precise, time-delimited, and contextually anchored functional milestones, thereby channeling attentional focus, energizing effort, promoting persistence, and fostering strategic problem-solving during physical rehabilitation.<\/p>\n The World Health Organization’s ICF framework<\/a> delineates health across three distinct levels: Body Functions\/Structures, Activities, and Participation. Traditional physical therapy historically focused on the impairment level (e.g., joint range of motion, muscle torque). The PSG deliberately shifts assessment upward to the Activities<\/em> and Participation<\/em> components, measuring functional interactions within real-world environments while accounting for personal and environmental contextual factors.<\/p>\n Modern clinical practice emphasizes shared decision-making<\/a> as an ethical and clinical imperative. The PSG creates an explicit communication scaffold that mitigates power asymmetries between practitioner and patient. In doing so, it directly strengthens the therapeutic alliance<\/em>—a construct repeatedly demonstrated to independently predict favorable treatment outcomes across chronic pain and musculoskeletal rehabilitation.<\/p>\n The validity of patient-specific measurement instruments, particularly descendants of the PSFS and PSK like the PSG, has been extensively substantiated within clinimetric and musculoskeletal health literature.<\/p>\n Content and face validity represent the foremost psychometric strengths of the PSG. Because the items are elicited directly from the patient’s phenomenological experience of their condition, the instrument guarantees $100%$<\/span> contextual relevance to the patient. Qualitative investigations into the PSG demonstrate that both patients and healthcare providers report exceptionally high face validity; patients feel actively heard and acknowledge that the assessed items represent the quintessential struggles of their daily living, avoiding the irrelevant or ceiling-compromised items common to fixed questionnaires.<\/p>\n Construct validity for patient-specific measures has been investigated by correlating change scores on individualized functional activities with established, validated condition-specific and generic outcome instruments:<\/p>\n Responsiveness—the ability to detect clinically meaningful change over time—is an area where patient-specific methods consistently outshine fixed nomothetic instruments. In empirical trials comparing the PSFS\/PSK methodology against generic HRQoL tools (SF-36) and regional impairment tools, patient-specific measures demonstrated larger standardized effect sizes and standardized response means (SRMs often exceeding $1.20$ to $1.60$). Because the PSG tracks only those activities in which the patient experienced actual baseline impairment, it avoids the statistical dilution caused by unresponsive, irrelevant questions embedded in standard inventories.<\/p>\n Despite the idiographic, non-standardized nature of the elicited activities, the clinimetric reliability of the underlying numerical rating scale and elicitation methodology has been rigorously documented.<\/p>\n In stable patient populations assessed over intervals of 24 to 72 hours prior to therapeutic intervention, patient-specific functional measures exhibit high test-retest reliability. Intraclass Correlation Coefficients ($ICC_{\\text{agreement}}$<\/span>) across various musculoskeletal settings consistently fall between 0.82 and 0.94<\/strong>. When clinicians receive formal instructional training in the standardized four-step PSG protocol, measurement variance attributable to administrative discrepancy is substantially minimized, preserving exceptional temporal stability.<\/p>\n Clinimetric precision is fundamentally defined by the Standard Error of Measurement (SEM) and the Minimal Detectable Change (MDC):<\/p>\n Because the Patient-Specific Goal-Setting Method is an idiographic, clinimetric measurement model<\/strong> rather than an invariant, nomothetic psychometric inventory, traditional confirmatory factor analysis (CFA) and exploratory factor analysis (EFA) are applied differently than they are to instruments with fixed content.<\/p>\n In traditional psychometrics (reflective models), items are assumed to be manifestations of a single, latent psychological trait (e.g., general anxiety or depressive affect). Under that paradigm, factor analysis seeks high inter-item correlation and invariant factor loadings ($\u03bb$<\/span>). Conversely, the PSG functions under a formative or clinimetric framework<\/em>:<\/p>\n Modern psychometric evaluations of patient-specific scales have utilized Rasch analysis and nonparametric Item Response Theory (IRT) to evaluate whether patient-generated items conform to a hierarchical continuum of functional difficulty. Rasch analyses confirm that when clinicians follow standardized elicitation instructions, the underlying rating scale (0 to 10) functions unidimensionally as an assessment of perceived functional capacity, exhibiting ordered response thresholds and absence of severe item-step disordering.<\/p>\n The Patient-Specific Goal-Setting Method is administered through a structured, interactive clinical interview accompanied by standardized documentation forms. Below are the structural parameters of the instrument:<\/p>\n The Patient-Specific Goal-Setting Method<\/strong> was finalized and published in its comprehensive standardized format in 2017<\/strong> by Dr. Anita Stevens through Zuyd University of Applied Sciences (Zuyd Hogeschool<\/em>). The underlying development of the instrument emerged from multi-year implementation studies evaluating the integration of goal-setting protocols within Dutch physical therapy practice.<\/p>\n The Patient-Specific Goal-Setting Method (PSG) does not utilize a static, pre-printed battery of fixed survey questions. Instead, it employs an idiographic elicitation and rating protocol structured into standardized clinical dialogue prompts and a dedicated 11-point rating scale. Below is the operationalized structure of the measurement protocol used during clinical administration:<\/p>\n The clinician introduces the purpose of the assessment to the patient and conducts a structured inquiry to identify meaningful functional problems:<\/p>\n For each elicited activity (up to 5), the patient assigns an initial baseline score based on their current functional ability using the standardized 0–10 numerical scale:<\/p>\n Rating Prompt:<\/p>\n “On a scale from 0 to 10, how would you rate your current ability to perform this specific activity?”<\/p>\n During follow-up or discharge assessments, present the identical activities identified in Phase 1 and prompt the patient:<\/p>\nKeywords<\/h2>\n
Authors<\/h2>\n
\n
Purpose<\/h2>\n
\n
Psychological Construct<\/h2>\n
Core Dimensions and Clinical Phases<\/h3>\n
\n
Theoretical Framework<\/h2>\n
1. Self-Determination Theory (SDT)<\/h3>\n
\n
2. Goal-Setting Theory<\/h3>\n
3. The International Classification of Functioning, Disability and Health (ICF)<\/h3>\n
4. Shared Decision-Making (SDM) and Working Alliance<\/h3>\n
Validity<\/h2>\n
Content and Face Validity<\/h3>\n
Construct and Convergent Validity<\/h3>\n
\n
Longitudinal Construct Validity (Responsiveness)<\/h3>\n
Reliability<\/h2>\n
Test-Retest Reliability<\/h3>\n
Measurement Error and Minimal Detectable Change<\/h3>\n
\n
Factor Analysis<\/h2>\n
Clinimetric vs. Psychometric Architecture<\/h3>\n
\n
Structural Evaluation via Item Response Theory and Rasch Modeling<\/h3>\n
Instrument \/ Measurement Tool<\/h2>\n
\n
\n
\n
\n $$\\text{PSG Composite Score} = \\frac{\\sum_{i=1}^{k} \\text{Score}_i}{k}$$<\/span>
\n where $k$<\/span> is the total number of patient-selected functional activities (typically $3 le k le 5$).<\/li>\n\n
Permissions & Fee and Test Year<\/h2>\n
\n
References<\/h2>\n
\n
Items of the Scale<\/h2>\n
Phase 1 — Problem Clarification & Activity Elicitation Prompts<\/h3>\n
\n
Target Activity Inventory & Baseline Ability Rating<\/h3>\n
\n
\n Execution Ability Rating (0 to 10):<\/em> _____ \/ 10\n <\/li>\n
\n Execution Ability Rating (0 to 10):<\/em> _____ \/ 10\n <\/li>\n
\n Execution Ability Rating (0 to 10):<\/em> _____ \/ 10\n <\/li>\n
\n Execution Ability Rating (0 to 10):<\/em> _____ \/ 10\n <\/li>\n
\n Execution Ability Rating (0 to 10):<\/em> _____ \/ 10\n <\/li>\n<\/ul>\nStandardized Rating Scale Anchors (Perceived Ability to Perform)<\/h3>\n
\n
Phase 2 & 3 — Goal Setting and Treatment Planning Protocol<\/h3>\n
\n
Phase 4 — Longitudinal Re-Evaluation Record<\/h3>\n
\n